105
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline

, , , , , , , , & show all
Pages 2757-2764 | Published online: 07 Nov 2016

References

  • AmalakuhanBMaselliDJMartinez-GarciaMAUpdate in Bronchiectasis 2014Am J Respir Crit Care Med2015192101155116126568240
  • ColePJInflammation: a two-edged sword – the model of bronchiectasisEur J Respir Dis Suppl19861476153533593
  • RobertsHRWellsAUMilneDGAirflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function testsThorax200055319820410679538
  • HoPLChanKNIpMSThe effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasisChest19981146159415989872194
  • NogradySGEvansWVDaviesBHReversibility of airways obstruction in bronchiectasisThorax1978335635637725832
  • PangJChanHSSungJYPrevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled studyThorax198944119489512595637
  • PasteurMCBiltonDHillATBritish Thoracic Society guideline for non-CF bronchiectasisThorax201065Suppl 1i1i5820627931
  • McShanePJNaureckasETTinoGStrekMENon-cystic fibrosis bronchiectasisAm J Respir Crit Care Med2013188664765623898922
  • Martínez-GarcíaMAPerpiñá-TorderaMRomán-SánchezPSoler-CataluñaJJInhaled steroids improve quality of life in patients with steady-state bronchiectasisRespir Med200610091623163216434174
  • TsangKWTanKCHoPLInhaled fluticasone in bronchiectasis: a 12 month studyThorax200560323924315741443
  • WongCJayaramLKaralusNAzithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trialLancet2012380984266066722901887
  • AltenburgJde GraaffCSStienstraYEffect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trialJAMA2013309121251125923532241
  • SerisierDJMartinMLMcGuckinMAEffect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trialJAMA2013309121260126723532242
  • HassanJASaadiahSRoslanHZainudinBMBronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasisRespirology19994442342610612580
  • TashkinDKestenSLong-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responsesChest200312351441144912740259
  • SheikhANolanDGreenstoneMLong-acting β2-agonists for bronchiectasisCochrane Database Syst Rev20014CD00215511687145
  • FrancoFSheikhAGreenstoneMShort acting β2 agonists for bronchiectasisCochrane Database Syst Rev20033CD00357212917973
  • GuanWJGaoYHXuGBronchodilator response in adults with bronchiectasis: correlation with clinical parameters and prognostic implicationsJ Thorac Dis201681142326904207
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
  • ChoiJKPaekDMLeeJONormal predictive values of spirometry in Korean populationTuberc Respir Dis2005583230242
  • PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
  • DoddJDLavelleLPFabreABradyDImaging in cystic fibrosis and non-cystic fibrosis bronchiectasisSemin Respir Crit Care Med201536219420625826587
  • HansellDMBankierAAMacMahonHMcLoudTCMüllerNLRemyJFleischner Society: glossary of terms for thoracic imagingRadiology2008246369772218195376
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • RennardSIAndersonWZuWallackRUse of a long-acting inhaled β2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116351087109211316640
  • ZuWallackRLMahlerDAReillyDSalmeterol plus theophylline combination therapy in the treatment of COPDChest200111961661167011399688
  • BleeckerEREmmettACraterGKnobilKKalbergCLung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibilityPulm Pharmacol Ther200821468268818541448
  • MahlerDADonohueJFBarbeeRAEfficacy of salmeterol xinafoate in the treatment of COPDChest1999115495796510208192
  • TashkinDPCelliBDecramerMBronchodilator responsiveness in patients with COPDEur Respir J200831474275018256071
  • MaoBYangJWLuHWXuJFAsthma and bronchiectasis exacerbationEur Respir J20164761680168627076584
  • SaynajakangasOKeistinenTTuuponenTKivelaSLLinks between hospital diagnoses of bronchiectasis and asthmaAllergy19975211112011229404566